1. Immortalization and characterization of a new canine mammary tumour cell line FR37-CMT.
- Author
-
Raposo, L. R., Roma‐Rodrigues, C., Faísca, P., Alves, M., Henriques, J., Carvalheiro, M. C., Corvo, M. L., Baptista, P. V., Pombeiro, A. J., and Fernandes, A. R.
- Subjects
XENOGRAFTS ,DRUG resistance ,CISPLATIN ,CELL lines ,VIMENTIN ,DOWNREGULATION ,TUMOR treatment ,LABORATORY mice - Abstract
Here we describe the establishment of a new canine mammary tumour ( CMT) cell line, FR37-CMT that does not show dependence on female hormonal signaling to induce tumour xenografts in NOD-SCID mice. FR37-CMT cell line has a stellate or fusiform shape, displays the ability to reorganize the collagen matrix, expresses vimentin, CD44 and shows the loss of E-cadherin which is considered a fundamental event in epithelial to mesenchymal transition ( EMT). The up-regulation of ZEB1, the detection of phosphorylated ERK1/2 and the downregulation of DICER1 and miR-200c are also in accordance with the mesenchymal characteristics of FR37-CMT cell line. FR37-CMT shows a higher resistance to cisplatin ( IC
50 >50 µM) and to doxorubicin ( IC50 >5.3 µM) compared with other CMT cell lines. These results support the use of FR37-CMT as a new CMT model that may assist the understanding of the molecular mechanisms underlying EMT, CMT drug resistance, fostering the development of novel therapies targeting CMT. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF